The efficacy of anti-PD-L1 antibodies in PitNET has been examined in both subcutaneous and intracranial murine models of Cushing disease, showing an efficacy in reducing tumor mass and hormone secretion and in blocking tumor proliferation [33]. The gene discussed is CD274; the disease is neoplasm.